You just read:

Revolution Medicines to Present Preclinical Data on Novel Inhibitors of Oncogenic RAS(ON) Mutants at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

News provided by

Revolution Medicines, Inc.

Oct 22, 2019, 07:30 ET